Duquesne Family Office — TEVA

How Duquesne Family Office's position in TEVA PHARMACEUTICAL INDS LTD changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarter	Shares	Value	% of portfolio	Change
Q1 2026	2,377,285	$71,604,000	2.44%	TRIM
Q4 2025	5,874,870	$183,355,000	4.34%	NEW